GSK Shifts Focus to US, Citing UK Drug Pricing

GSKs Dame Emma Walmsley highlights US as top pharmaceutical investment destination, citing tariff deal and market leadership, as UK rivals like AstraZeneca and Merck pause investments, raising concerns for UKs pharmaceutical industrys future.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.